G. Weitz-Schmidt
Novartis Pharma AG
Preclinical Research
Basel
Switzerland
Name/email consistency: high
- Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., Hommel, U. Nat. Med. (2001)